Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Vaxxinity, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% | |
| Cost of goods sold | | 100.0% | | 100.0% | 18.0% | 113.9% | 51182.4% | |
| Gross profit | | 0.0% | | 0.0% | 82.0% | -13.9% | -51082.4% | |
| Research and development | | 952.0% | | 1434.8% | 47232.0% | 136.8% | 68752.9% | |
| General and administrative | | 615.3% | | 835.8% | 13400.0% | 42.1% | 50494.1% | |
| Depreciation | | 48.8% | | 41.6% | 1856.0% | 2036.0% | 1658823.5% | |
| EBIT | | -1567.3% | | -2270.5% | -60550.0% | -192.8% | -119152.9% | |
| Pre-tax income | | -1533.3% | | -2282.9% | -60778.0% | -193.6% | -188358.8% | |
| Income taxes | | 0.0% | | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | | -1533.3% | | -2282.9% | -60778.0% | -193.6% | -188358.8% | |
|